IIIM1

IIIM1 is an orally active anti-inflammatory peptide. It alleviates symptoms of experimental autoimmune encephalomyelitis (EAE) by stimulating the proliferation of regulatory T cells and inducing them to produce RA1, which balances cytokine levels. IIIM1 is applicable for research on multiple sclerosis (MS) .

[C@@H](CC1=CC=C(O)C=C1)(NC([C@H](CC2=CN=CN2)NC(CNC([C@H](CCCCN)N)=O)=O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(O)=O)=O)[C@@H](C)C)=O)CCCNC(=N)N)=O)CCC(O)=O)=O)C)=O